S100P, a potential novel prognostic marker in colorectal cancer

Oncology Reports

Volumn 28, Issue 1, 2012, Pages 303-310

  Wang, Qiang ^a   Zhang, Yue Ning ^a,b   Lin, Guo Le ^a   Qiu, Hui Zhong ^a   Wu, Bin ^a   Wu, Hai Yan ^a   Zhao, Yu ^a   Chen, Yuan Jia ^a   Lu, Chong Mei ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; Colorectal cancer; Methylation; Prognosis; S100P

Indexed keywords

MESSENGER RNA; PROTEIN S100P; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER PROGNOSIS; CANCER STAGING; CANCER TISSUE; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DEMETHYLATION; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOMETHYLATION; MAJOR CLINICAL STUDY; MALE; METHYLATION; OVERALL SURVIVAL; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE STUDY; S100P GENE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84861538065     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1794     Document Type: Article

References (33)

1. Sung JJ, Lau JY, Goh KL and Leung WK: Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol 6: 871-876, 2005. (Pubitemid 41614799)
2. Yang L, Parkin DM, Li LD, et al: Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br J Cancer 90: 2157-2166, 2004. (Pubitemid 38869723)
3. Garcia M, Jemal A, Ward EM, Center MM, Hao Y, Siegel RL and Thun MJ: Global Cancer Facts and Figures 2007. American Cancer Society, Atlanta, GA, 2007.
4. Saridaki Z, Papadatos-Pastos D, Tzardi M, et al: BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients' outcome. Br J Cancer 102: 1762-1768, 2010.
5. Benatti P, Gafa R, Barana D, et al: Microsatellite instability and colorectal cancer prognosis. Clin Cancer Res 11: 8332-8340, 2005. (Pubitemid 41746945)
6. de Maat MF, van de Velde CJ, Benard A, et al: Identification of a quantitative MINT locus methylation profile predicting local regional recurrence of rectal cancer. Clin Cancer Res 16: 2811-2818, 2010.
7. Kontos CK, Papadopoulos IN, Fragoulis EG and Scorilas A: Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma. Br J Cancer 102: 1384-1390, 2010.
8. Scott LC, Evans TR, Cassidy J, et al: Cytokeratin 18 in plasma of patients with gastrointestinal adenocarcinoma as a biomarker of tumour response. Br J Cancer 101: 410-417, 2009.
9. Walther A, Johnstone E, Swanton C, et al: Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 9: 489-499, 2009.
10. Bertagnolli MM, Warren RS, Niedzwiecki D, et al: p27Kip1 in stage III colon cancer: implications for outcome following adjuvant chemotherapy in cancer and leukemia group B protocol 89803. Clin Cancer Res 15: 2116-2122, 2009.
11. Duffy MJ, van Dalen A, Haglund C, et al: Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer 43: 1348-1360, 2007. (Pubitemid 46874070)
12. 2+ binding properties. Eur J Biochem 207: 541-547, 1992.
13. Emoto Y, Kobayashi R, Akatsuka H and Hidaka H: Purification and characterization of a new member of the S-100 protein family from human placenta. Biochem Biophys Res Commun 182: 1246-1253, 1992.
14. Dowen SE, Crnogorac-Jurcevic T, Gangeswaran R, et al: Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer. Am J Pathol 166: 81-92, 2005. (Pubitemid 40051662)
15. Missiaglia E, Blaveri E, Terris B, et al: Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis. Int J Cancer 112: 100-112, 2004. (Pubitemid 39249497)
16. Guerreiro Da Silva ID, Hu YF, Russo IH, et al: S100P calcium-binding protein overexpression is associated with immortalization of human breast epithelial cells in vitro and early stages of breast cancer development in vivo. Int J Oncol 16: 231-240, 2000.
17. Schor AP, Carvalho FM, Kemp C, et al: S100P calcium-binding protein expression is associated with high-risk proliferative lesions of the breast. Oncol Rep 15: 3-6, 2006.
18. Mousses S, Bubendorf L, Wagner U, et al: Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays. Cancer Res 62: 1256-1260, 2002. (Pubitemid 34407773)
19. Parkkila S, Pan PW, Ward A, et al: The calcium-binding protein S100P in normal and malignant human tissues. BMC Clin Pathol 8: 2, 2008.
20. Fuentes MK, Nigavekar SS, Arumugam T, et al: RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways. Dis Colon Rectum 50: 1230-1240, 2007. (Pubitemid 47087458)
21. Birkenkamp-Demtroder K, Olesen SH, Sorensen FB, et al: Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut 54: 374-384, 2005. (Pubitemid 40299094)
22. Herman JG, Graff JR, Myohanen S, et al: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826, 1996. (Pubitemid 26296693)
23. Usadel H, Brabender J, Danenberg KD, et al: Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res 62: 371-375, 2002. (Pubitemid 34106406)
24. Reddy AN, Jiang WW, Kim M, et al: Death-associated protein kinase promoter hypermethylation in normal human lymphocytes. Cancer Res 63: 7694-7698, 2003. (Pubitemid 37466698)
25. Wang G, Platt-Higgins A, Carroll J, et al: Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients. Cancer Res 66: 1199-1207, 2006. (Pubitemid 43165991)
26. Diederichs S, Bulk E, Steffen B, et al: S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer. Cancer Res 64: 5564-5569, 2004. (Pubitemid 39095550)
27. Surowiak P, Maciejczyk A, Materna V, et al: Unfavourable prognostic significance of S100P expression in ovarian cancers. Histopathology 51: 125-128, 2007. (Pubitemid 46976362)
28. Arumugam T, Simeone DM, Van Golen K and Logsdon CD: S100P promotes pancreatic cancer growth, survival, and invasion. Clin Cancer Res 11: 5356-5364, 2005. (Pubitemid 41060808)
29. Beer DG, Kardia SL, Huang CC, et al: Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 8: 816-824, 2002.
30. Bartling B, Rehbein G, Schmitt WD, et al: S100A2-S100P expression profile and diagnosis of non-small cell lung carcinoma: impairment by advanced tumour stages and neoadjuvant chemotherapy. Eur J Cancer 43: 1935-1943, 2007. (Pubitemid 47284868)
31. Sato N, Fukushima N, Matsubayashi H and Goggins M: Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling. Oncogene 23: 1531-1538, 2004. (Pubitemid 38406515)
32. Wang Q, Williamson M, Bott S, et al: Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer. Oncogene 26: 6560-6565, 2007. (Pubitemid 47530597)
33. Rehbein G, Simm A, Hofmann HS, et al: Molecular regulation of S100P in human lung adenocarcinomas. Int J Mol Med 22: 69-77, 2008.